| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Research Abstract |
Correlation of 18^F-AMT uptake and cellular growth activity evaluated by Ki-67 labeling index was assessed in patients with head and neck cancer. As a result, significant correlation of both indexes was confirmed. As for 131^I-MIBG therapy, the early therapeutic response by the measurement of serum catecholamine 1 week after injection of 131^I-MIBG was assessed and serum catecholamine is proved to be significantly related with better response. Furthermore, diagnostic utility of FDG-PET/CT comparing with 123I-MIBG scintigraphy and X-ray CT in the evaluation of therapeutic effect of 131^I-MIBG was assessed and it is confirmed that FDG-PET/CT is useful in the evaluation of therapeutic response of 131^I-MIBG in malignant pheochromocytoma.
|
